NEMOD IMMUNTHERAPIE AG has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are MOLOGEN FORSCHUNGS ENTWICKLUNG, TODO TOMOKI and U S ARMY MEDICAL RES INST OF I.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Goletz Steffen | 16 |
#2 | Christensen Peter Astrup | 7 |
#3 | Kristensen Peter | 6 |
#4 | Stahn Renate | 5 |
#5 | Karsten Uwe | 4 |
#6 | Scheper Rik J | 3 |
#7 | Jeschke Udo | 3 |
#8 | Fichtner Iduna | 3 |
#9 | Masterson Alan | 3 |
#10 | Larsen Martin | 3 |
Publication | Filing date | Title |
---|---|---|
AU2003266236A8 | Method for the production of an immunostimulating mucin (muc1) | |
DE10303664A1 | Detection molecules for the treatment and detection of tumors | |
DE10256900A1 | Tumor-specific recognition molecules | |
DE10238846A1 | Active fusion proteins and processes for their production | |
CA2428141A1 | Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis of inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases | |
DE10139428A1 | Preparation of dendritic cells, useful e.g. as antitumor or antimicrobial vaccines, by treating CD124- and CD116-positive cells with stimulatory molecules | |
DE10135039C1 | Method for isolating large variances of specific molecules for a target molecule from phagemid gene libraries |